Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be ...
Before Exelexis’ Cabometyx can pass muster with the FDA in its hopeful neuroendocrine tumors indication next April, it will ...
Sac-TMT, also known as SKB264 or MK-2870, represents the first asset in Kelun’s multitarget, multibillion-dollar ADC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback